AWCI
Alpine Woods Capital Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.49M | Buy |
5,594
+9
| +0.2% | +$4.01K | 0.59% | 58 |
|
|
2025
Q1 | $2.71M | Buy |
5,585
+3,255
| +140% | +$1.58M | 0.68% | 54 |
|
|
2024
Q4 | $938K | Sell |
2,330
-2,000
| -46% | -$805K | 0.18% | 111 |
|
|
2024
Q3 | $2.17M | Sell |
4,330
-1,203
| -22% | -$604K | 0.38% | 80 |
|
|
2024
Q2 | $2.59M | Buy |
5,533
+140
| +3% | +$65.6K | 0.4% | 80 |
|
|
2024
Q1 | $2.12M | Sell |
5,393
-2,047
| -28% | -$804K | 0.42% | 83 |
|
|
2023
Q4 | $3.03M | Buy |
7,440
+996
| +15% | +$405K | 0.45% | 69 |
|
|
2023
Q3 | $2.24M | Buy |
6,444
+548
| +9% | +$191K | 0.36% | 89 |
|
|
2023
Q2 | $2.08M | Buy |
5,896
+1,018
| +21% | +$358K | 0.32% | 88 |
|
|
2023
Q1 | $1.54M | Sell |
4,878
-185
| -4% | -$58.3K | 0.23% | 111 |
|
|
2022
Q4 | $1.46M | Buy |
5,063
+383
| +8% | +$111K | 0.21% | 107 |
|
|
2022
Q3 | $1.36M | Buy |
4,680
+493
| +12% | +$143K | 0.18% | 117 |
|
|
2022
Q2 | $1.18M | Sell |
4,187
-245
| -6% | -$69K | 0.15% | 126 |
|
|
2022
Q1 | $1.16M | Buy |
4,432
+227
| +5% | +$59.3K | 0.12% | 136 |
|
|
2021
Q4 | $923K | Buy |
4,205
+1,001
| +31% | +$220K | 0.09% | 147 |
|
|
2021
Q3 | $581K | Buy |
3,204
+310
| +11% | +$56.2K | 0.06% | 175 |
|
|
2021
Q2 | $584K | Buy |
2,894
+110
| +4% | +$22.2K | 0.06% | 175 |
|
|
2021
Q1 | $598K | Buy |
2,784
+3
| +0.1% | +$644 | 0.07% | 178 |
|
|
2020
Q4 | $657K | Buy |
2,781
+1,855
| +200% | +$438K | 0.08% | 170 |
|
|
2020
Q3 | $252K | Buy |
+926
| New | +$252K | 0.04% | 219 |
|